NYSE:UNH - UnitedHealth Group Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $346.68
  • Forecasted Upside: 14.16 %
  • Number of Analysts: 25
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 20 Buy Ratings
  • 1 Strong Buy Ratings
$303.68
▼ -4.32 (-1.40%)
1 month | 3 months | 12 months
Get New UnitedHealth Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UNH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UNH

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$346.68
▲ +14.16% Upside Potential
This price target is based on 25 analysts offering 12 month price targets for UnitedHealth Group in the last 3 months. The average price target is $346.68, with a high forecast of $389.00 and a low forecast of $285.00. The average price target represents a 14.16% upside from the last price of $303.68.
Buy
The current consensus among 25 contributing investment analysts is to buy stock in UnitedHealth Group.

Past Monthly Recommendations

Move your mouse over past months for details

  • 1 strong buy ratings
  • 15 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/8/2019
  • 1 strong buy ratings
  • 13 buy ratings
  • 4 hold ratings
  • 0 sell ratings
8/6/2019
  • 1 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/4/2019
  • 1 strong buy ratings
  • 17 buy ratings
  • 4 hold ratings
  • 0 sell ratings
2/2/2020
  • 1 strong buy ratings
  • 17 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/2/2020
  • 1 strong buy ratings
  • 19 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/31/2020
  • 1 strong buy ratings
  • 20 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/29/2020
  • 1 strong buy ratings
  • 20 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/29/2020

Latest Recommendations

  • 1 strong buy ratings
  • 20 buy ratings
  • 4 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/19/2020ArgusDowngradeBuy ➝ HoldLow
i
10/16/2020UBS GroupBoost Price TargetNeutral$319.00 ➝ $330.00Low
i
10/15/2020Jefferies Financial GroupBoost Price TargetHold$310.00 ➝ $335.00Medium
i
10/15/2020Royal Bank of CanadaBoost Price TargetOutperform$384.00 ➝ $389.00Medium
i
10/15/2020OppenheimerBoost Price TargetOutperform$353.00 ➝ $375.00Medium
i
10/15/2020Raymond JamesBoost Price TargetStrong-Buy$350.00 ➝ $355.00Medium
i
10/15/2020SVB LeerinkBoost Price TargetOutperform$370.00 ➝ $373.00Medium
i
Rating by D. Ha at SVB Leerink LLC
10/15/2020Piper SandlerBoost Price TargetOverweight$350.00 ➝ $385.00Medium
i
10/14/2020Royal Bank of CanadaReiterated RatingBuyLow
i
10/14/2020Credit Suisse GroupSet Price TargetBuy$335.00Low
i
Rating by A.J. Rice at Credit Suisse Group AG
10/13/2020BarclaysBoost Price TargetOverweight$322.00 ➝ $365.00Low
i
8/28/2020Bank of AmericaBoost Price TargetBuy$351.00 ➝ $365.00Low
i
7/16/2020Royal Bank of CanadaBoost Price Target$341.00 ➝ $384.00Low
i
7/16/2020Morgan StanleyReiterated RatingBuy$371.00Low
i
7/16/2020OppenheimerBoost Price TargetOutperform$343.00 ➝ $353.00Low
i
7/16/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$293.00 ➝ $312.00Low
i
7/16/2020SVB LeerinkBoost Price TargetOutperform$360.00 ➝ $370.00Low
i
Rating by D. Ha at SVB Leerink LLC
7/16/2020Raymond JamesBoost Price TargetStrong-Buy$325.00 ➝ $350.00Low
i
7/16/2020Credit Suisse GroupBoost Price TargetOutperform$325.00 ➝ $335.00Medium
i
7/16/2020StephensBoost Price TargetOverweight$325.00 ➝ $335.00Medium
i
7/16/2020CitigroupBoost Price TargetBuy$339.00 ➝ $357.00Medium
i
Rating by Ralph Giacobbe at Citigroup Inc.
7/16/2020Piper SandlerBoost Price TargetOverweight$339.00 ➝ $350.00Medium
i
7/15/2020MizuhoReiterated RatingBuy$315.00Low
i
Rating by Ann Hynes at Mizuho
7/10/2020Jefferies Financial GroupBoost Price TargetHold$283.00 ➝ $295.00Low
i
7/9/2020Royal Bank of CanadaReiterated RatingBuy$341.00Medium
i
7/1/2020SVB LeerinkInitiated CoverageOutperform$360.00Medium
i
Rating by S. Davis at SVB Leerink LLC
6/5/2020The Goldman Sachs GroupInitiated CoverageBuy$384.00High
i
Rating by Stephen Tanal at The Goldman Sachs Group, Inc.
6/2/2020StephensBoost Price TargetOverweight$310.00 ➝ $325.00Low
i
5/27/2020Credit Suisse GroupReiterated RatingBuyMedium
i
5/21/2020SunTrust BanksBoost Price TargetBuy$340.00 ➝ $360.00Low
i
4/30/2020Morgan StanleyBoost Price TargetOverweight$289.00 ➝ $371.00High
i
4/24/2020CitigroupLower Price TargetBuy$346.00 ➝ $339.00Low
i
Rating by Ralph Giacobbe at Citigroup Inc.
4/16/2020Raymond JamesLower Price Target$340.00 ➝ $325.00High
i
Rating by John Ransom at Raymond James
4/16/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$308.00 ➝ $293.00High
i
4/16/2020Credit Suisse GroupLower Price TargetOutperform$330.00 ➝ $325.00High
i
4/16/2020CowenBoost Price TargetPositive ➝ Outperform$320.00 ➝ $340.00High
i
4/15/2020StephensBoost Price TargetOverweight$300.00 ➝ $310.00Low
i
4/13/2020SunTrust BanksLower Price TargetBuy$360.00 ➝ $340.00Low
i
Rating by David S Macdonald at SunTrust Banks, Inc.
3/29/2020BarclaysReiterated RatingBuy$322.00High
i
Rating by Steven Valiquette at Barclays PLC
3/27/2020Morgan StanleyLower Price TargetOverweight$341.00 ➝ $281.00Low
i
3/20/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$308.00High
i
3/4/2020CitigroupReiterated RatingBuyMedium
i
Rating by Ralph Giacobbe at Citigroup Inc.
2/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$297.00 ➝ $362.00Medium
i
1/19/2020BarclaysReiterated RatingBuyLow
i
Rating by Steven Valiquette at Barclays PLC
1/16/2020OppenheimerBoost Price TargetOutperform$312.00 ➝ $343.00Low
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
1/16/2020UBS GroupBoost Price TargetNeutral$279.00 ➝ $304.00Low
i
1/16/2020Cantor FitzgeraldBoost Price TargetOverweight$315.00 ➝ $330.00Low
i
Rating by Steven Halper at Cantor Fitzgerald
1/16/2020CitigroupBoost Price TargetBuy$286.00 ➝ $346.00Low
i
1/15/2020StephensBoost Price TargetOverweight ➝ Overweight$325.00 ➝ $333.00Low
i
1/8/2020Credit Suisse GroupBoost Price TargetOutperform$320.00 ➝ $330.00High
i
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$276.00 ➝ $361.00Medium
i
12/19/2019ArgusReiterated RatingPositive ➝ Buy$340.00Low
i
12/18/2019SunTrust BanksBoost Price TargetBuy$335.00 ➝ $350.00Low
i
Rating by David S Macdonald at SunTrust Banks, Inc.
12/11/2019Wells Fargo & CompanyReiterated RatingOverweight$318.00 ➝ $335.00Low
i
12/10/2019Evercore ISIInitiated CoverageBuy$285.00Medium
i
Rating by Michael Newshel at Evercore ISI
12/5/2019Raymond JamesBoost Price TargetBuy$300.00 ➝ $320.00Low
i
Rating by John Ransom at Raymond James
12/4/2019UBS GroupBoost Price TargetNeutral$257.00 ➝ $279.00Low
i
12/4/2019BMO Capital MarketsReiterated RatingMarket Perform$310.00Medium
i
Rating by Matthew Borsch at BMO Capital Markets
12/4/2019Cantor FitzgeraldBoost Price TargetBuy$310.00 ➝ $315.00Medium
i
Rating by Steven Halper at Cantor Fitzgerald
12/4/2019Piper Jaffray CompaniesBoost Price TargetOverweight$312.00 ➝ $325.00Medium
i
12/4/2019Credit Suisse GroupBoost Price TargetOutperform$293.00 ➝ $320.00Medium
i
12/4/2019Wells Fargo & CompanyBoost Price TargetOutperform ➝ In-Line$288.00 ➝ $318.00Medium
i
12/2/2019BarclaysBoost Price TargetOverweight$260.00 ➝ $305.00Low
i
Rating by Steven Valiquette at Barclays PLC
11/26/2019MizuhoReiterated RatingBuy$270.00 ➝ $300.00Low
i
Rating by Ann Hynes at Mizuho
11/22/2019Morgan StanleyReiterated RatingBuy$294.00 ➝ $312.00Low
i
Rating by Ricky Goldwasser at Morgan Stanley
11/18/2019SunTrust BanksReiterated RatingBuy$310.00 ➝ $335.00Low
i
Rating by David S Macdonald at SunTrust Banks, Inc.
10/17/2019MizuhoInitiated CoverageBuy$270.00Low
i
10/17/2019UBS GroupLower Price TargetNeutral$281.00 ➝ $257.00Medium
i
Rating by Whit Mayo at UBS Group AG
10/16/2019CitigroupLower Price TargetBuy$299.00 ➝ $286.00Low
i
Rating by Ralph Giacobbe at Citigroup Inc.
10/15/2019Cantor FitzgeraldSet Price TargetBuy$310.00Low
i
Rating by Steven Halper at Cantor Fitzgerald
10/10/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$300.00 ➝ $235.00High
i
10/8/2019Cantor FitzgeraldSet Price TargetBuy$310.00Low
i
Rating by Steven Halper at Cantor Fitzgerald
10/8/2019BarclaysSet Price TargetBuy$260.00Low
i
Rating by Steven Valiquette at Barclays PLC
9/30/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$292.00 ➝ $249.00Medium
i
9/26/2019Morgan StanleyLower Price TargetOverweight$298.00 ➝ $294.00Medium
i
Rating by Ricky Goldwasser at Morgan Stanley
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$263.00High
i
8/29/2019Credit Suisse GroupSet Price TargetBuy$293.00Low
i
7/19/2019Royal Bank of CanadaSet Price TargetBuy$311.00Medium
i
Rating by Ben Hendrix at Royal Bank of Canada
7/19/2019OppenheimerSet Price TargetBuy$312.00Medium
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
7/19/2019Cantor FitzgeraldSet Price TargetBuy$310.00N/A
i
Rating by Steven Halper at Cantor Fitzgerald
7/19/2019Raymond JamesBoost Price TargetBuy$265.00 ➝ $300.00Low
i
7/15/2019Cleveland ResearchReiterated RatingBuyMedium
i
Rating by Steve Willoughby at Cleveland Research
7/12/2019Morgan StanleyBoost Price TargetOverweight$285.00 ➝ $298.00Low
i
Rating by Zachary Sopcak at Morgan Stanley
5/10/2019CitigroupUpgradeNeutral ➝ Buy$247.00 ➝ $280.00Low
i
Rating by Ralph Giacobbe at Citigroup Inc.
4/23/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$238.00Low
i
4/17/2019CitigroupLower Price TargetNeutral ➝ Neutral$288.00 ➝ $247.00Medium
i
4/17/2019BarclaysLower Price TargetOverweight ➝ Overweight$290.00 ➝ $270.00Medium
i
4/17/2019Bank of AmericaReiterated RatingBuy ➝ Buy$320.00 ➝ $290.00Medium
i
4/17/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$315.00 ➝ $285.00Medium
i
4/17/2019Raymond JamesLower Price TargetStrong-Buy ➝ Strong-Buy$310.00 ➝ $265.00Medium
i
Rating by Michael J. Baker at Raymond James
4/17/2019SunTrust BanksLower Price TargetBuy$300.00High
i
2/8/2019Credit Suisse GroupReiterated RatingBuy$310.00Low
i
1/16/2019OppenheimerBoost Price TargetOutperform$300.00 ➝ $305.00Low
i
1/15/2019Cantor FitzgeraldReiterated RatingBuy$310.00High
i
1/14/2019StephensInitiated CoverageOverweight$287.00Medium
i
1/11/2019Cleveland ResearchReiterated RatingBuyLow
i
Rating by Steve Willoughby at Cleveland Research
12/17/2018ArgusBoost Price TargetBuy ➝ Buy$285.00 ➝ $295.00Low
i
11/28/2018Raymond JamesSet Price TargetBuy$310.00Low
i
Rating by Michael J. Baker at Raymond James
11/28/2018OppenheimerBoost Price TargetOutperform$295.00 ➝ $300.00Low
i
11/28/2018Piper Jaffray CompaniesBoost Price TargetOverweight$312.00High
i
11/27/2018BMO Capital MarketsSet Price TargetBuy$310.00Low
i
Rating by Matthew Borsch at BMO Capital Markets
11/21/2018Cantor FitzgeraldReiterated RatingBuy$310.00Medium
i
10/18/2018BMO Capital MarketsBoost Price TargetOutperform$310.00Low
i
Rating by Matthew Borsch at BMO Capital Markets
10/18/2018ArgusBoost Price TargetPositive ➝ Buy$285.00Low
i
10/17/2018OppenheimerBoost Price TargetOutperform$276.00 ➝ $295.00Low
i
10/17/2018Royal Bank of CanadaBoost Price TargetOutperform$308.00Low
i
10/17/2018Piper Jaffray CompaniesBoost Price TargetOverweight$300.00Low
i
10/17/2018Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$304.00 ➝ $310.00Low
i
10/17/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$315.00 ➝ $320.00Medium
i
10/12/2018BarclaysBoost Price TargetOverweight$265.00 ➝ $280.00Low
i
10/3/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$270.00 ➝ $311.00Low
i
9/24/2018Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$285.00 ➝ $304.00Low
i
9/17/2018CowenInitiated CoverageOutperform$308.00Low
i
9/10/2018CitigroupDowngradeBuy ➝ Neutral$288.00High
i
9/5/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$278.00 ➝ $305.00Low
i
8/9/2018Cantor FitzgeraldReiterated RatingBuy$300.00Low
i
7/18/2018SVB LeerinkReiterated RatingOutperformLow
i
Rating by A. Gupte at SVB Leerink LLC
7/18/2018Morgan StanleyBoost Price TargetOverweight ➝ $255.42$277.00 ➝ $278.00Low
i
7/18/2018CitigroupBoost Price TargetBuy ➝ $255.42$275.00 ➝ $288.00Medium
i
7/18/2018Royal Bank of CanadaBoost Price TargetOutperform ➝ $255.42$282.00 ➝ $284.00Medium
i
7/17/2018The Goldman Sachs GroupReiterated RatingBuy$277.00Low
i
7/5/2018Cantor FitzgeraldReiterated RatingBuy$300.00Medium
i
6/21/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Positive$285.00 ➝ $300.00Low
i
Rating by Matthew Borsch at BMO Capital Markets
6/11/2018SunTrust BanksInitiated CoverageBuy$300.00Medium
i
6/7/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Buy$275.00 ➝ $285.00Low
i
4/18/2018Piper Jaffray CompaniesReiterated RatingBuy$270.00Low
i
4/18/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$260.00 ➝ $270.00Low
i
4/18/2018OppenheimerBoost Price TargetOutperform$260.00 ➝ $276.00Low
i
4/18/2018Cantor FitzgeraldBoost Price TargetOverweight$300.00Low
i
4/18/2018Royal Bank of CanadaReiterated RatingBuyLow
i
4/18/2018Sanford C. BernsteinSet Price TargetBuy$259.00 ➝ $275.00Low
i
4/18/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$275.00 ➝ $277.00Low
i
4/18/2018JPMorgan Chase & Co.Boost Price TargetOverweight$266.00Low
i
3/9/2018Credit Suisse GroupReiterated RatingBuyLow
i
3/8/2018Cantor FitzgeraldReiterated RatingBuy$280.00Medium
i
3/8/2018BarclaysInitiated CoverageOverweight ➝ Overweight$265.00Medium
i
1/18/2018ArgusBoost Price TargetBuy$270.00Medium
i
1/17/2018Credit Suisse GroupBoost Price TargetOutperform$252.00 ➝ $260.00Low
i
1/17/2018OppenheimerBoost Price TargetOutperform$260.00 ➝ $240.00Low
i
1/17/2018Cantor FitzgeraldBoost Price TargetOverweight$280.00Low
i
1/17/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy$260.00Low
i
1/17/2018CitigroupBoost Price TargetBuy ➝ Buy$235.00 ➝ $268.00Medium
i
1/17/2018BMO Capital MarketsBoost Price TargetOutperform$14.50 ➝ $275.00Medium
i
1/17/2018Royal Bank of CanadaBoost Price TargetPositive ➝ Outperform$269.00 ➝ $280.00Medium
i
1/17/2018Piper Jaffray CompaniesReiterated RatingBuy$259.00High
i
1/16/2018Cantor FitzgeraldReiterated RatingBuy$235.00Low
i
1/12/2018Evercore ISIReiterated RatingOutperform ➝ Outperform$235.00 ➝ $255.00Low
i
1/3/2018The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$269.00Low
i
12/27/2017Credit Suisse GroupReiterated RatingOutperform ➝ BuyLow
i
12/25/2017Cantor FitzgeraldReiterated RatingBuy$235.00Low
i
12/6/2017Raymond JamesReiterated RatingBuyLow
i
Rating by Michael J. Baker at Raymond James
12/1/2017Sanford C. BernsteinBoost Price TargetOutperform$219.00 ➝ $246.00Low
i
12/1/2017SVB LeerinkReiterated RatingOutperformLow
i
12/1/2017Jefferies Financial GroupReiterated RatingBuy$248.00Low
i
11/29/2017Piper Jaffray CompaniesBoost Price TargetOverweight$242.00Low
i
11/29/2017Royal Bank of CanadaBoost Price TargetOutperform$244.00High
i
11/29/2017Credit Suisse GroupReiterated RatingOutperform ➝ Positive$233.00 ➝ $240.00High
i
11/29/2017OppenheimerBoost Price TargetOutperform$215.00 ➝ $225.00High
i
11/29/2017Wells Fargo & CompanyReiterated RatingOutperform$230.00 ➝ $245.00High
i
11/27/2017Cantor FitzgeraldReiterated RatingBuy$225.00High
i
11/2/2017Credit Suisse GroupInitiated CoverageOutperform$233.00N/A
i
10/24/2017MizuhoReiterated RatingBuyN/A
i
Rating by Sheryl Skolnick at Mizuho
10/19/2017ArgusBoost Price TargetBuy$215.00 ➝ $230.00N/A
i
10/18/2017OppenheimerBoost Price TargetBuy ➝ Outperform$215.00 ➝ $205.00N/A
i
10/18/2017Bank of AmericaBoost Price TargetBuy$230.00 ➝ $240.00N/A
i
10/18/2017CitigroupBoost Price TargetBuy$213.00 ➝ $235.00N/A
i
10/18/2017Morgan StanleyBoost Price TargetOverweight$215.00 ➝ $235.00N/A
i
10/18/2017SVB LeerinkReiterated RatingBuy$225.00 ➝ $240.00N/A
i
10/18/2017Cantor FitzgeraldBoost Price TargetOverweight$225.00N/A
i
10/17/2017Piper Jaffray CompaniesBoost Price TargetOverweight$228.00N/A
i
10/17/2017Cantor FitzgeraldReiterated RatingBuy$208.00N/A
i
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$250.00 ➝ $250.00N/A
i
10/13/2017Jefferies Financial GroupBoost Price TargetBuy$215.00 ➝ $225.00N/A
i
10/10/2017Sanford C. BernsteinReiterated RatingOutperform$210.00N/A
i
8/29/2017Cantor FitzgeraldReiterated RatingBuyLow
i
8/24/2017UBS GroupReiterated RatingOverweightLow
i
8/18/2017Jefferies Financial GroupReiterated RatingBuy$215.00Low
i
8/17/2017Morgan StanleyBoost Price TargetOverweight$210.00 ➝ $215.00Low
i
8/11/2017CowenReiterated RatingOutperform$175.00 ➝ $220.00Low
i
7/22/2017Sanford C. BernsteinReiterated RatingOutperform$190.00 ➝ $210.00Low
i
7/21/2017OppenheimerReiterated RatingOutperform$203.00 ➝ $205.00Low
i
7/21/2017Cantor FitzgeraldReiterated RatingOverweight$208.00Low
i
7/20/2017Royal Bank of CanadaReiterated RatingBuy$212.00Low
i
7/19/2017BarclaysBoost Price TargetOverweight$200.00 ➝ $217.00Low
i
7/19/2017CitigroupBoost Price TargetBuy$195.00 ➝ $213.00Low
i
7/19/2017UBS GroupReiterated RatingBuy ➝ Positive$194.00 ➝ $213.00Medium
i
7/18/2017MizuhoSet Price TargetBuy ➝ Buy$200.00 ➝ $235.00Low
i
Rating by Sheryl Skolnick at Mizuho
7/14/2017CowenReiterated RatingBuyLow
i
7/14/2017Bank of AmericaBoost Price TargetBuy$210.00 ➝ $214.00Low
i
7/13/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$187.00 ➝ $197.00Low
i
7/13/2017Credit Suisse GroupReiterated RatingOutperform$195.00 ➝ $200.00Low
i
7/10/2017Sanford C. BernsteinReiterated RatingOutperform$190.00Low
i
7/7/2017Cantor FitzgeraldReiterated RatingBuy$205.00Low
i
6/28/2017Stifel NicolausReiterated RatingBuy$185.00Low
i
6/28/2017Morgan StanleyBoost Price TargetOverweight$202.00 ➝ $210.00Low
i
6/9/2017SVB LeerinkReiterated RatingOutperformLow
i
6/6/2017Morgan StanleyInitiated CoverageOverweight ➝ Overweight$202.00Medium
i
5/19/2017Jefferies Financial GroupReiterated RatingBuy$192.00Medium
i
4/24/2017CIBCBoost Price TargetOutperform$186.00 ➝ $187.00Low
i
4/22/2017Cantor FitzgeraldReiterated RatingOverweight$200.00 ➝ $205.00Low
i
Rating by J. France at Cantor Fitzgerald
4/22/2017UBS GroupReiterated RatingBuy$193.00 ➝ $194.00N/A
i
Rating by A.J. Rice at UBS Group AG
4/22/2017Jefferies Financial GroupReiterated RatingBuy$186.00 ➝ $192.00Low
i
4/22/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$183.00 ➝ $187.00Low
i
4/21/2017OppenheimerReiterated RatingOutperform$186.00 ➝ $187.00Low
i
4/19/2017Credit Suisse GroupBoost Price TargetOutperform$185.00 ➝ $188.00Medium
i
4/19/2017Evercore ISIReiterated RatingOutperform$185.00Low
i
4/19/2017Stifel NicolausReiterated RatingBuy$185.00Low
i
4/18/2017MizuhoBoost Price TargetBuy$178.00 ➝ $200.00High
i
4/6/2017Cantor FitzgeraldReiterated RatingOverweight$200.00Low
i
Rating by J. France at Cantor Fitzgerald
4/5/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$183.00Low
i
2/28/2017SVB LeerinkBoost Price TargetBuy ➝ Hold$195.00 ➝ $210.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
2/21/2017Wells Fargo & CompanyReiterated RatingOutperformN/A
i
2/6/2017Cantor FitzgeraldInitiated CoverageOverweight$200.00N/A
i
Rating by J. France at Cantor Fitzgerald
1/24/2017SVB LeerinkReiterated RatingOutperform$185.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
1/23/2017ArgusReiterated RatingBuy$170.00N/A
i
1/10/2017Jefferies Financial GroupReiterated RatingBuy$186.00N/A
i
1/9/2017BarclaysReiterated RatingBuy$187.00N/A
i
1/3/2017Piper Jaffray CompaniesInitiated CoverageOverweight$188.00N/A
i
12/16/2016Jefferies Financial GroupReiterated RatingBuy$186.00N/A
i
12/7/2016Cantor FitzgeraldUpgradeHold ➝ Buy$157.32 ➝ $200.00N/A
i
Rating by J. France at Cantor Fitzgerald
12/1/2016Sanford C. BernsteinReiterated RatingOutperform$177.00N/A
i
12/1/2016UBS GroupSet Price TargetBuy$180.00 ➝ $193.00N/A
i
Rating by a.j. rice at UBS Group AG
11/30/2016CowenSet Price TargetBuy$175.00N/A
i
Rating by Christine Arnold at Cowen Inc
11/30/2016OppenheimerBoost Price TargetOutperform$161.00 ➝ $171.00N/A
i
11/30/2016JPMorgan Chase & Co.Boost Price TargetOverweight$170.00 ➝ $178.00N/A
i
11/30/2016Credit Suisse GroupBoost Price TargetOutperform$168.00 ➝ $179.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
11/30/2016Royal Bank of CanadaBoost Price TargetOutperform$168.00 ➝ $175.00N/A
i
11/30/2016Jefferies Financial GroupBoost Price TargetBuy$168.00 ➝ $182.00N/A
i
11/30/2016SVB LeerinkBoost Price TargetOutperform$185.00 ➝ $195.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
11/30/2016MizuhoUpgradeNeutral ➝ Buy$178.00N/A
i
Rating by Sheryl Skolnick at Mizuho
11/23/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Ana Gupte at SVB Leerink LLC
11/9/2016MizuhoDowngradeBuy ➝ NeutralN/A
i
Rating by Sheryl Skolnick at Mizuho
10/21/2016Credit Suisse GroupReiterated RatingOutperform$155.00 ➝ $160.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
10/19/2016SVB LeerinkSet Price TargetBuy$165.00 ➝ $175.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
10/19/2016MizuhoBoost Price TargetBuy$160.00 ➝ $169.00N/A
i
Rating by Sheryl Skolnick at Mizuho
10/16/2016Jefferies Financial GroupReiterated RatingBuy$163.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
10/4/2016Jefferies Financial GroupReiterated RatingBuy$163.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
9/22/2016Evercore ISIInitiated CoverageBuy$155.00N/A
i
9/19/2016UBS GroupSet Price TargetBuy$165.00N/A
i
Rating by a.j. rice at UBS Group AG
9/6/2016CowenSet Price TargetBuy$150.00N/A
i
Rating by christine arnold at Cowen Inc
9/6/2016Sanford C. BernsteinReiterated RatingOutperform$178.00N/A
i
8/31/2016UBS GroupReiterated RatingBuyN/A
i
Rating by a.j. rice at UBS Group AG
8/23/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by David Windley at Jefferies Financial Group Inc.
8/22/2016UBS GroupReiterated RatingBuyN/A
i
Rating by steven fisher at UBS Group AG
8/21/2016SVB LeerinkReiterated RatingOutperformN/A
i
Rating by Ana Gupte at SVB Leerink LLC
7/22/2016OppenheimerReiterated RatingOutperform$145.00 ➝ $161.00N/A
i
7/22/2016ArgusUpgradeHold ➝ Buy$170.00N/A
i
7/20/2016CitigroupBoost Price TargetBuy$148.00 ➝ $164.00N/A
i
7/20/2016BarclaysBoost Price TargetOverweight$151.00 ➝ $164.00N/A
i
7/20/2016Royal Bank of CanadaReiterated RatingOutperform$157.00 ➝ $165.00N/A
i
7/20/2016FBR & CoReiterated RatingOutperform$145.00 ➝ $155.00N/A
i
Rating by Steven Halper at FBR & Co
7/20/2016Credit Suisse GroupReiterated RatingBuy$148.00 ➝ $155.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
7/20/2016SVB LeerinkReiterated RatingOutperform$155.00 ➝ $165.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
7/20/2016Royal Bank of CanadaBoost Price TargetOutperform$157.00 ➝ $165.00N/A
i
7/19/2016MizuhoBoost Price TargetBuy$156.00 ➝ $160.00N/A
i
Rating by Sheryl Skolnick at Mizuho
7/19/2016WedbushReiterated RatingOutperform$165.00N/A
i
7/15/2016Sanford C. BernsteinInitiated CoverageOutperformN/A
i
7/14/2016UBS GroupReiterated RatingBuyN/A
i
6/29/2016Credit Suisse GroupReiterated RatingBuy$148.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
6/28/2016Wolfe ResearchInitiated CoverageOutperform$172.00N/A
i
6/27/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Ana Gupte at SVB Leerink LLC
6/15/2016Sanford C. BernsteinInitiated CoverageOutperform$171.00N/A
i
6/10/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Scott Fidel at Credit Suisse Group AG
6/10/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Ana Gupte at SVB Leerink LLC
5/18/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Scott Fidel at Credit Suisse Group AG
5/18/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by Andrew Schenker at Morgan Stanley
5/17/2016Jefferies Financial GroupReiterated RatingBuy$153.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
4/20/2016FBR & CoReiterated RatingBuyN/A
i
Rating by Steven Halper at FBR & Co
4/20/2016MizuhoBoost Price TargetBuy$150.00 ➝ $156.00N/A
i
Rating by Sheryl Skolnick at Mizuho
4/19/2016WedbushReiterated RatingOutperform$138.00N/A
i
4/19/2016FBR & CoBoost Price TargetOutperform$130.00 ➝ $145.00N/A
i
Rating by Steven Halper at FBR & Co
4/19/2016SVB LeerinkReiterated RatingOutperform$150.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
4/14/2016FBR & CoReiterated RatingOutperform$130.00 ➝ $145.00N/A
i
Rating by Steven Halper at FBR & Co
4/8/2016Cleveland ResearchInitiated CoverageBuy$155.00N/A
i
4/5/2016CowenReiterated RatingOutperformN/A
i
Rating by Christine Arnold at Cowen Inc
3/17/2016FBR & CoReiterated RatingOutperformN/A
i
Rating by Steven Halper at FBR & Co
3/14/2016MizuhoBoost Price TargetBuy$131.00 ➝ $150.00N/A
i
Rating by Sheryl Skolnick at Mizuho
3/6/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Scott Fidel at Credit Suisse Group AG
3/3/2016Credit Suisse GroupBoost Price TargetOutperform$133.00 ➝ $138.00N/A
i
Rating by Ralph Giacobbe at Credit Suisse Group AG
2/16/2016Piper Jaffray CompaniesReiterated RatingOverweight$142.00N/A
i
2/9/2016CowenReiterated RatingBuyN/A
i
Rating by Christine Arnold at Cowen Inc
2/9/2016The Goldman Sachs GroupLower Price Target$130.00 ➝ $124.00N/A
i
1/20/2016Piper Jaffray CompaniesReiterated RatingOverweight$149.00 ➝ $142.00N/A
i
1/20/2016FBR & CoReiterated RatingOutperform$130.00N/A
i
Rating by Steven Halper at FBR & Co
1/20/2016Jefferies Financial GroupBoost Price TargetBuy$135.00 ➝ $136.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
1/19/2016WedbushReiterated RatingOutperform$138.00N/A
i
1/15/2016CowenReiterated RatingBuyN/A
i
Rating by Christine Arnold at Cowen Inc
1/8/2016Jefferies Financial GroupReiterated RatingBuy$142.00 ➝ $135.00N/A
i
12/17/2015Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Ralph Giacobbe at Credit Suisse Group AG
12/16/2015Credit Suisse GroupInitiated CoverageOutperform$133.00N/A
i
12/2/2015140166Reiterated RatingPositive$150.00N/A
i
Rating by Chris Rigg at 140166
12/2/2015Stifel NicolausReiterated RatingBuy$148.00N/A
i
Rating by Thomas Carroll at Stifel Nicolaus
12/2/2015OppenheimerReiterated RatingOutperform$140.00N/A
i
12/2/2015BMO Capital MarketsBoost Price TargetOutperform$130.00 ➝ $138.00N/A
i
11/22/2015SVB LeerinkReiterated RatingBuy$150.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
11/22/2015Cantor FitzgeraldReiterated RatingHold$135.00N/A
i
Rating by Joseph France at Cantor Fitzgerald
11/20/2015Raymond JamesLower Price TargetStrong-Buy$146.00 ➝ $140.00N/A
i
11/20/2015JPMorgan Chase & Co.Lower Price TargetOverweight$150.00 ➝ $140.00N/A
i
Rating by Justin Lake at JPMorgan Chase & Co.
11/20/2015Jefferies Financial GroupLower Price TargetBuy$142.00N/A
i
11/20/2015BMO Capital MarketsLower Price Target$139.00 ➝ $130.00N/A
i
11/20/2015MizuhoLower Price TargetBuy$155.00 ➝ $131.00N/A
i
Rating by Sheryl Skolnick at Mizuho
11/19/2015FBR & CoLower Price TargetOutperform$135.00 ➝ $130.00N/A
i
Rating by Steven Halper at FBR & Co
(Data available from 10/29/2015 forward)
UnitedHealth Group logo
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The OptumInsight segment offers software and information products, advisory consulting arrangements, and services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Read More

Today's Range

Now: $303.68
$301.46
$309.48

50 Day Range

MA: $314.50
$292.14
$331.42

52 Week Range

Now: $303.68
$187.72
$335.65

Volume

3,123,532 shs

Average Volume

4,179,051 shs

Market Capitalization

$288.60 billion

P/E Ratio

17.44

Dividend Yield

1.62%

Beta

0.68